Skip to main content

Table 1 Patients’ characteristics

From: The association between smoking and breast cancer characteristics and outcome

Population No. patients

All

Hx smokinga

Current Smokinga

Pack years

(662)

Yes (173)

No (439)

P value

Yes (101)

No (508)

P value

≥30 (66)

0–29 (518)

P value

Median Age (range)

61 (34–85)

60 (36–83)

60 (34–85)

0.449

56 (36–75)

61 (34–85)

<0.001

62 (43–83)

60 (34–85)

0.197

Ethnicity

 Ashkenazi

49.5%

46.5%

50.1%

0.165

43.9%

50.0%

0.449

52.3%

49.5%

0.188

 Sephardic

41.5%

47.6%

39.1%

 

49.0%

40.1%

 

46.2%

40.0%

 

 Arab

2.1%

0.6%

2.8%

 

1.0%

2.4%

 

1.5%

2.2%

 

 Other

7%

5.3%

8.0%

 

6.1%

7.5%

 

0%

8.3%

 

 Family Hx of breast cancer (yes, %)

39.7%

38%

40.3%

0.608

42.4%

39.3%

0.564

38.5%

40.4%

0.764

 Postmenopausal (yes, %)

78%

76.7%

77.4%

0.914

64.4%

79.7%

0.002

85.1%

76.4%

0.122

 Hx of HRT usage

21.8%

23.4%

22.2%

0.746

21%

22.8%

0.793

29.2%

21.7%

0.206

  1. aData regarding smoking was retrieved during the first visit at the oncologist clinic. Current smokers were defined as patients who actively smoked at the time of breast cancer diagnosis. Patients with history of smoking were defined as ever smoker
  2. Abbreviations: HRT hormonal replacement therapy; Hx-history
  3. - Data were not available for: Ethnicity (n = 34); Family history (n = 19); HRT usage (n = 41); Hx smoking (n = 49); Menopausal status (n = 28); PY (n = 77); smoking status (n = 52)
  4. - Cohort included patients with ER positive, HER2 negative disease